Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)
Clinical trial NCT01082549 · COMPLETED
Trial details
- NCT number
- NCT01082549
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-04-01
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.